Skip to main content

Advertisement

Table 1 The baseline characteristics of the study participants

From: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics

  Mean Std. Deviation
Age 64.2 9.2
Disease duration 6.8 4.5
Sex (male/female) n 89 89
Wearing off (+/-) n 58 120
Dyskinesia (+/-) n 42 136
Levodopa mg 344.1 202.8
Levodopa (+/-) n 154 24
Dopamine agonist levodopa equivalent dose (mg) [12] 166.3 121.1
Total levodopa equivalent dose (mg) [12]a 592.0 317.6
Unified Parkinson’s Disease Rating Scale   
Part I 0.7 1.2
Part II 5.6 3.9
Part III 15.7 8.4
Part IV 1.7 2.2
Total 23.7 11.8
Modified Hoehn and Yahr stage 2.1 0.6
Parkinson’s disease Questionnaire-39   
Mobility 10.4 9.1
Activities of daily living 5.2 5.1
Emotional well-being 6.0 4.4
Stigma 3.2 2.8
Social support 1.4 1.9
Cognitions 4.0 3.0
Communication 1.7 2.2
Body discomfort 2.5 2.6
Total 34.4 24.2
  1. a: not including istradefylline and zonisamide